Total Payments
$6,920
2024 Payments
$2,339
Companies
29
Transactions
428
Medicare Patients
1,114
Medicare Billing
$90,056
Payment Breakdown by Category
Food & Beverage$6,897 (99.7%)
Education$23.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,897 | 426 | 99.7% |
| Education | $23.00 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,355 | 89 | $0 (2024) |
| Novo Nordisk Inc | $712.80 | 55 | $0 (2024) |
| Amgen Inc. | $503.00 | 28 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $469.79 | 23 | $0 (2024) |
| Abbott Laboratories | $413.62 | 23 | $0 (2024) |
| IBSA Pharma Inc. | $366.25 | 22 | $0 (2024) |
| Corcept Therapeutics | $350.59 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $333.16 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $304.35 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $274.01 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,339 | 125 | Lilly USA, LLC ($373.25) |
| 2023 | $1,492 | 96 | Lilly USA, LLC ($545.21) |
| 2022 | $1,749 | 122 | Lilly USA, LLC ($336.96) |
| 2021 | $1,341 | 85 | Novo Nordisk Inc ($254.15) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $73.52 | General |
| Category: Diabetes Care | ||||||
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $43.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Rare Disease | ||||||
| 11/15/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Diabetes Care | ||||||
| 11/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 238 | 356 | $48,374 | $23,051 |
| 2022 | 4 | 254 | 344 | $47,203 | $25,548 |
| 2021 | 4 | 285 | 380 | $43,334 | $23,943 |
| 2020 | 4 | 337 | 389 | $39,798 | $17,514 |
Total Patients
1,114
Total Services
1,469
Medicare Billing
$90,056
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 116 | 172 | $29,102 | $15,056 | 51.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 81 | 95 | $11,286 | $5,965 | 52.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Facility | 2023 | 41 | 89 | $7,986 | $2,030 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 105 | 167 | $28,256 | $15,331 | 54.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 102 | 126 | $14,969 | $7,931 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 31 | 33 | $2,574 | $1,339 | 52.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 16 | 18 | $1,404 | $946.56 | 67.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 115 | 155 | $18,414 | $10,179 | 55.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 57 | 79 | $13,480 | $7,349 | 54.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 89 | 113 | $8,866 | $4,559 | 51.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 24 | 33 | $2,574 | $1,855 | 72.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 122 | 160 | $19,008 | $8,655 | 45.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 74 | 80 | $6,240 | $2,799 | 44.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 57 | $7,088 | $2,579 | 36.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 38 | 39 | $3,042 | $2,103 | 69.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 42 | $3,796 | $1,036 | 27.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 11 | 11 | $624.00 | $342.73 | 54.9% |
About Larry Weckesser, APRN
Larry Weckesser, APRN is a Family healthcare provider based in Mount Vernon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2017. The National Provider Identifier (NPI) number assigned to this provider is 1124542006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Larry Weckesser, APRN has received a total of $6,920 in payments from pharmaceutical and medical device companies, with $2,339 received in 2024. These payments were reported across 428 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,897).
As a Medicare-enrolled provider, Weckesser has provided services to 1,114 Medicare beneficiaries, totaling 1,469 services with total Medicare billing of $90,056. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Mount Vernon, OH
- Active Since 08/01/2017
- Last Updated 03/10/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1124542006
Products in Payments
- JARDIANCE (Drug) $735.95
- MOUNJARO (Drug) $456.91
- Ozempic (Drug) $352.85
- Korlym (Drug) $350.59
- Repatha (Biological) $335.79
- Tirosint (Drug) $291.02
- LEQVIO (Drug) $268.40
- FARXIGA (Drug) $260.17
- TZIELD (Biological) $257.67
- SYNTHROID (Drug) $252.14
- Rybelsus (Drug) $221.21
- FREESTYLE LIBRE 3 (Device) $221.11
- STRENSIQ (Biological) $219.94
- HUMULIN (Drug) $212.12
- SOLIQUA 100/33 (Biological) $197.15
- Kerendia (Drug) $160.28
- GVOKE HYPOPEN (Drug) $139.11
- EVENITY (Biological) $124.21
- CYCLOSET (Drug) $122.75
- BAQSIMI (Drug) $120.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Mount Vernon
Mrs. Amanda Mckee, Msn, Fnp, MSN, FNP
Family — Payments: $217,153
Family $217,153
Ms. Vicki Chapman
Family — Payments: $50,014
Family $50,014
Keirsten Montgomery, Rn, Bsn, Fnp-C, RN, BSN, FNP-C
Family — Payments: $12,016
Family $12,016
Ms. Barbara Lynch, Fnp, FNP
Family — Payments: $8,811
Family $8,811
Laura Eichenlaub, Np-C, NP-C
Family — Payments: $5,388
Family $5,388
Ramonda Dugas, Np, NP
Family — Payments: $5,148
Family $5,148